🎉 M&A multiples are live!
Check it out!

908 Devices Valuation Multiples

Discover revenue and EBITDA valuation multiples for 908 Devices and similar public comparables like Philips, InfuSystem, and Myomo.

908 Devices Overview

About 908 Devices

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.


Founded

2012

HQ

United States of America
Employees

71

Website

908devices.com

Financials

LTM Revenue $56.8M

LTM EBITDA -$19.9M

EV

$128M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

908 Devices Financials

908 Devices has a last 12-month revenue (LTM) of $56.8M and a last 12-month EBITDA of -$19.9M.

In the most recent fiscal year, 908 Devices achieved revenue of $59.6M and an EBITDA of -$67.8M.

908 Devices expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See 908 Devices valuation multiples based on analyst estimates

908 Devices P&L

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $56.8M XXX $59.6M XXX XXX XXX
Gross Profit $34.7M XXX $29.9M XXX XXX XXX
Gross Margin 61% XXX 50% XXX XXX XXX
EBITDA -$19.9M XXX -$67.8M XXX XXX XXX
EBITDA Margin -35% XXX -114% XXX XXX XXX
EBIT -$37.0M XXX -$49.3M XXX XXX XXX
EBIT Margin -65% XXX -83% XXX XXX XXX
Net Profit -$43.7M XXX -$72.2M XXX XXX XXX
Net Margin -77% XXX -121% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

908 Devices Stock Performance

As of July 11, 2025, 908 Devices's stock price is $7.

908 Devices has current market cap of $249M, and EV of $128M.

See 908 Devices trading valuation data

908 Devices Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$128M $249M XXX XXX XXX XXX $-1.31

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

908 Devices Valuation Multiples

As of July 11, 2025, 908 Devices has market cap of $249M and EV of $128M.

908 Devices's trades at 2.2x EV/Revenue multiple, and -1.9x EV/EBITDA.

Equity research analysts estimate 908 Devices's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

908 Devices has a P/E ratio of -5.7x.

See valuation multiples for 908 Devices and 12K+ public comps

908 Devices Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $249M XXX $249M XXX XXX XXX
EV (current) $128M XXX $128M XXX XXX XXX
EV/Revenue 2.3x XXX 2.2x XXX XXX XXX
EV/EBITDA -6.4x XXX -1.9x XXX XXX XXX
EV/EBIT -3.5x XXX -2.6x XXX XXX XXX
EV/Gross Profit 3.7x XXX n/a XXX XXX XXX
P/E -5.7x XXX -3.4x XXX XXX XXX
EV/FCF -5.5x XXX -4.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get 908 Devices Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

908 Devices Margins & Growth Rates

908 Devices's last 12 month revenue growth is 7%

908 Devices's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $1.1M for the same period.

908 Devices's rule of 40 is -61% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

908 Devices's rule of X is -18% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for 908 Devices and other 12K+ public comps

908 Devices Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 7% XXX 5% XXX XXX XXX
EBITDA Margin -35% XXX -114% XXX XXX XXX
EBITDA Growth -61% XXX n/a XXX XXX XXX
Rule of 40 -61% XXX -107% XXX XXX XXX
Bessemer Rule of X XXX XXX -18% XXX XXX XXX
Revenue per Employee XXX XXX $0.8M XXX XXX XXX
Opex per Employee XXX XXX $1.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 43% XXX XXX XXX
Opex to Revenue XXX XXX 133% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

908 Devices Public Comps

See public comps and valuation multiples for Medical Devices and Laboratory Services comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

908 Devices M&A and Investment Activity

908 Devices acquired  XXX companies to date.

Last acquisition by 908 Devices was  XXXXXXXX, XXXXX XXXXX XXXXXX . 908 Devices acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by 908 Devices

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About 908 Devices

When was 908 Devices founded? 908 Devices was founded in 2012.
Where is 908 Devices headquartered? 908 Devices is headquartered in United States of America.
How many employees does 908 Devices have? As of today, 908 Devices has 71 employees.
Who is the CEO of 908 Devices? 908 Devices's CEO is Dr. Kevin J. Knopp, PhD.
Is 908 Devices publicy listed? Yes, 908 Devices is a public company listed on NAS.
What is the stock symbol of 908 Devices? 908 Devices trades under MASS ticker.
When did 908 Devices go public? 908 Devices went public in 2020.
Who are competitors of 908 Devices? Similar companies to 908 Devices include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of 908 Devices? 908 Devices's current market cap is $249M
What is the current revenue of 908 Devices? 908 Devices's last 12 months revenue is $56.8M.
What is the current revenue growth of 908 Devices? 908 Devices revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of 908 Devices? Current revenue multiple of 908 Devices is 2.3x.
Is 908 Devices profitable? Yes, 908 Devices is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of 908 Devices? 908 Devices's last 12 months EBITDA is -$19.9M.
What is 908 Devices's EBITDA margin? 908 Devices's last 12 months EBITDA margin is -35%.
What is the current EV/EBITDA multiple of 908 Devices? Current EBITDA multiple of 908 Devices is -6.4x.
What is the current FCF of 908 Devices? 908 Devices's last 12 months FCF is -$23.1M.
What is 908 Devices's FCF margin? 908 Devices's last 12 months FCF margin is -41%.
What is the current EV/FCF multiple of 908 Devices? Current FCF multiple of 908 Devices is -5.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.